STAAR SURGICAL COSTAA決算レポート
Nasdaq · ヘルスケア · 眼科用品
スターサージカル社は眼科分野に特化したグローバルな医療機器企業です。眼鏡やコンタクトレンズに代わる低侵襲視力矯正用の埋め込み型コラマーレンズ（ICL）や眼科手術向け関連製品を開発・製造・販売し、北米、欧州、アジア太平洋などの主要市場で事業を展開しています。
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| Broadwood Partners, L.P. | 22.10% | 10.8M | ▲ +1.40pp | 2024-01-10 |
| BlackRock, Inc. | 15.50% | 7.6M | 変動なし | 2024-11-12 |
| The Vanguard Group | 11.20% | 5.5M | — | 2024-02-13 |
| Nos. of above persons | 3.18% | 1.6M | ▼ -5.93pp | 2024-09-06 |
インサイダー取引
Net 90d: +$12.27M · buys $12.27M / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-03-14 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 19.6K | $0.00 | $0 |
| 2026-03-14 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 9.8K | $0.00 | $0 |
| 2026-03-14 | Magda Michna | Chief Development Officer | Option exercise | 14.7K | $0.00 | $0 |
| 2026-03-14 | Magda Michna | Chief Development Officer | Option exercise | 2.9K | $0.00 | $0 |
| 2026-03-13 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 316.0K | $18.61 | $5.88M |
| 2026-03-13 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 0 | $0.00 | $0 |
| 2026-03-12 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 8.2K | $0.00 | $0 |
| 2026-03-12 | Magda Michna | Chief Development Officer | Option exercise | 6.2K | $0.00 | $0 |
| 2026-03-12 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 299.4K | $18.12 | $5.42M |
| 2026-03-12 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 0 | $0.00 | $0 |
1–10 of 12
1 / 2 ページ